Exercise for stroke prevention
The neglected prescription
Citation Manager Formats
Make Comment
See Comments

Article Information
- First Published December 21, 2016.
Article Versions
- Previous version (December 21, 2016 - 13:00).
- You are viewing the most recent version of this article.
Author Disclosures
- Seemant Chaturvedi, MD and
- Fadi Nahab, MD
- Seemant Chaturvedi, MD and
1. Consultant for Merck 2. Executive Committee member for ACT I study and CREST 2 study
NONE
NONE
Editorial board member of NEUROLOGY, Journal of Stroke & Cerebrovascular Disease; Assistant Editor for STROKE and contributing editor for NEJM Journal Watch Neurology
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Clinical studies supported by Boehringer-Ingelheim
NINDS for serving on grant review committee; FDA for serving on circulatory devices panel
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Compensation for expert witness testimony
- Fadi Nahab, MD
NONE
NONE
Medtronic
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Expert witness for defendant. Legal consultation for plaintiffs and defendants.
- From the Department of Neurology and Stroke Program (S.C.), University of Miami Miller School of Medicine, FL; and Department of Neurology and Pediatrics (F.N.), Emory University, Atlanta, GA.
- Correspondence to Dr. Chaturvedi: SChaturvedi{at}med.miami.edu
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Risk factor status and vascular events in patients with symptomatic intracranial stenosisS. Chaturvedi, T. N. Turan, M. J. Lynn et al.Neurology, November 26, 2007 -
Article
Relationship between risk factor control and vascular events in the SAMMPRIS trialTanya N. Turan, Azhar Nizam, Michael J. Lynn et al.Neurology, December 21, 2016 -
Article
Optimal combination secondary prevention drug treatment and stroke outcomesJong-Ho Park, Bruce Ovbiagele et al.Neurology, November 19, 2014 -
Article
Statin therapy in acute cardioembolic stroke with no guidance-based indicationHong-Kyun Park, Ji Sung Lee, Keun-Sik Hong et al.Neurology, April 09, 2020